Virtusa / Life Sciences / Biotech and Pharma
Disruptive solutions that span the clinical continuum

The US pharmaceutical industry is facing an uphill battle. A shrinking government healthcare budget, pro-generics policies, and competition from emerging markets coupled with long drug development times have decelerated industry growth. That said, demographic changes have created the need for new, niche drugs and treatments. To combat this deceleration and take advantage of new opportunities, pharmaceutical companies are adopting alternative clinical and business strategies such as outcome-based reimbursement.

In contrast, biotechnology continues to gain traction with their focus on specialty and personalized medicine. Today most of the top life sciences product sales are from this segment.

Regardless of their growth status, both pharmaceutical and biotechnology companies are challenged by the rising costs of delivering new products to patients. In order to support decision-making, lower costs, and ultimately, compete, firms need to adopt key technologies for robust reporting, predictive analytics, and risk-based monitoring across the clinical continuum.

We have a growing suite of consultative solutions

Connected Care for Clinical Trials

A patient-centric platform to takes your trials to the next level

Connected Care for Clinical Trials

Our Connected Care platform offerings are the definition of patient-centricity. We help reduce your patients’ anxiety and confusion of choices, help them make informed decisions, and provide an overall better clinical trial experience through improved connected care coordination. In turn, your clinical trial ecosystem sees improved patient treatment adherence and has a minimized level of patient dropouts. Another benefit is increased volume and quality of data that allows researchers to make more informed R&D decisions. Connected Care is a key enabler for your goal achievement, serving as a centralized, secure, and compliant platform that is highly scalable and gives your patients the resources they need to stay committed to trial success.

Cognitive Pharmacovigilance (PV) Intake

Maximize your ability to identify and process adverse event scenarios

Cognitive Pharmacovigilance (PV) Intake

Our cloud-based, omni-channel solution proactively identifies and manages risk within a shifting compliance environment. This ground-breaking solution supports intake from devices, sensors, social media, and other intelligence channels, which alleviates reliance on voluntary patient and provider reporting. Standardized processes and analytics increase visibility into performance, improve operational efficiencies, avoid fines and increase the therapeutic value of your drug and device products.

Cloud Migration

Enhance your scalability and efficiency with the cloud

Cloud Migration

Faced with growing pressure to bolster shrinking pipelines, accelerate innovation, streamline R&D and improve the rate of return, pharmaceutical companies are exploring new business models and technologies that can drive innovation, improve collaboration and accelerate new product development. Cloud computing is transforming most industry sectors across the world, and have had an intense impact on life sciences. The cloud—specifically, is the need of the hour to improve productivity and enable teams to collaborate more effectively. The savings and agility provided by cloud computing have solidified IT as vital to meeting the strategic ambitions of every enterprise. Whether or not a business has adopted cloud, its stakeholders are undoubtedly considering its potential to contribute not only to cost reduction, but also to the growth of the organization.